Circulating Long Noncoding RNAs CASC2 and TUG1 as Noninvasive Diagnostic Biomarkers for Hepatitis C–Related Hepatocellular Carcinoma

Authors

  • Nahla Ibrahim Elattar, Hanan samir Ahmed, Ola Elsayed Abdel Latif Elnaggar, Nahla Elsayed Elgammal Author

DOI:

https://doi.org/10.48047/99a0ps89

Keywords:

Long Noncoding RNAs, CASC2 , TUG1, Hepatitis C–Related Hepatocellular Carcinoma

Abstract

Background: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide, with chronic hepatitis C virus (HCV) infection representing one of its most important etiological factors. Despite advances in surveillance strategies, early diagnosis of HCV-related  HCC remains suboptimal. Conventional diagnostic tools

Downloads

Download data is not yet available.

References

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424.

Downloads

Published

2024-11-20

How to Cite

Circulating Long Noncoding RNAs CASC2 and TUG1 as Noninvasive Diagnostic Biomarkers for Hepatitis C–Related Hepatocellular Carcinoma (Nahla Ibrahim Elattar, Hanan samir Ahmed, Ola Elsayed Abdel Latif Elnaggar, Nahla Elsayed Elgammal , Trans.). (2024). Cuestiones De Fisioterapia, 53(03), 6837-6851. https://doi.org/10.48047/99a0ps89